In June 2022, at 41, Lourdes Milian learned through a routine mammogram that she had stage 0 ductal carcinoma in situ (DCIS), a form of breast cancer. Under the care of Susan Kesmodel, M.D., director of breast surgical oncology and co-leader of the Breast Site Disease Group at Sylvester, she elected to have a nipple-sparing double mastectomy. With three young children and concerns about recurrence, Milian found reassurance in Sylvester’s multidisciplinary approach, advanced surgical options and emphasis on patient choice. The procedure was successful, and she remains cancer-free, grateful not only for the outcome, but for the expert care that helped her move forward with confidence.
In June 2022, at 41, Lourdes Milian learned through a routine mammogram that she had stage 0 ductal carcinoma in situ (DCIS), a form of breast cancer. Under the care of Susan Kesmodel, M.D., director of breast surgical oncology and co-leader of the Breast Site Disease Group at Sylvester, she elected to have a nipple-sparing double mastectomy. With three young children and concerns about recurrence, Milian found reassurance in Sylvester’s multidisciplinary approach, advanced surgical options and emphasis on patient choice. The procedure was successful, and she remains cancer-free, grateful not only for the outcome, but for the expert care that helped her move forward with confidence.